期刊
MEDCHEMCOMM
卷 7, 期 9, 页码 1716-1729出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6md00287k
关键词
-
资金
- US National Institutes of Health [R01M098453]
- University of Pisa
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098453] Funding Source: NIH RePORTER
The altered metabolism observed in cancer cells generally consists of increased glucose uptake and glycolytic activity. This is associated with an overexpression of glucose transporter proteins (GLUTs), which facilitate glucose uptake across the plasma membrane and play a crucial role in the survival of cancer cells. Therefore, GLUTs are considered as suitable targets for treatment of cancer. Herein we review some of the most relevant GLUT inhibitors that have been recently developed as prospective anticancer agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据